jRCTs061230077招募中不适用
Efficacy of butyric Acid preparations in patients with unresectable hepatocellular carcinoma underGoing systEmic chemotheRapy (EAGER study)
未提供0 个研究点目标入组 25 人开始时间: 2024年4月24日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 25
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •1 18 age old over
- •2 Regardless of gender
- •3 Patients diagnosed with unresectable hepatocellular carcinoma
- •4 Patients who will receive treatment with Durvalumab and Tremelimumab
- •5 Patients who have been fully informed consent
排除标准
- •1 Patients with Child-Pugh score over 8
- •2 Patients used to have hypersensitivity with butyric acid
- •3 Being pregnant or possibly pregnant
- •4 Patients who judged as inappropriate candidate by the chief medical examine
结局指标
主要结局
-
progression free survival
次要结局
未报告次要终点
研究者
相似试验
招募中
3 期
Efficacy of butyric acid preparations in patients with hepatocellular carcinoma undergoing chemotherapynresectable hepatocellular carcinomaUnresectable HCCJPRN-jRCTs061230077Otsuka Motoyuki25
招募中
3 期
Butyrate supplements improve efficacy in patients with moderate to severe chronic spontaneous urticaria, A randomized, double-blind, placebo-controlled trialchronic urticariabutyrateUAS7TCTR20220302003Department of Medicine of Phramongkutklao hospital40
已完成
不适用
Butyrate: effect of oral administration in patients with mild hypertensiohigh blood pressure10057166hypertensionNL-OMON49499Academisch Medisch Centrum50
已完成
不适用
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated SymptomsGut HealthNCT06419231Supplement Formulators, Inc.143
尚未招募
2 期
Investigating Sodium Butyrate as Treatment for Anorexia NervosaAnorexia NervosaACTRN12624000368538Monash University15